BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 15, 2008
View Archived Issues
Novel antibacterial agents reported in recent patent literature
Read More
Recent patents disclose new compounds for treating cancer
Read More
Neurogen suspends phase II/III insomnia study of adipiplon
Read More
Erythropoietin shows benefits for motoneuron degeneration treatment in preclinical studies
Read More
A novel positive allosteric modulator of nAChR7 under preclinical development for schizophrenia
Read More
European Commission grants orphan designation to Marqibo for ALL
Read More
Abraxis receives approval to market Abraxane for breast cancer in China
Read More
Amgen presents positive top-line denosumab results from phase III pivitol trial
Read More
Clinical results from blonanserin for the treatment of cognitive deficits in schizophrenia
Read More
Medarex provides updates on antibody development
Read More
Cardiome reports positive phase IIb data for oral vernakalant
Read More
FDA approves OncoGenex's SPA for phase III trial of OGX-011 in HRPC
Read More
NanoViricides reports excellent efficacy of EKC-Cide in first animal study
Read More
ValiRx to acquire Cronos Therapeutics
Read More
Edison's second-generation coenzyme Q10 analogue enters phase I clinical trials
Read More
Moderate efficacy of ARG-201 in patients with late-phase systemic sclerosis / News in Context
Read More
Luminex and ViroNovative sign license agreement for human metapneumovirus rights
Read More
Map commences phase III MAP-0004 trial in patients with migraine
Read More
Theravance presents clinical results from its LAMA Respiratory Program
Read More
FDA accepts Genta's amendment to NDA for Genasense in CLL as complete response
Read More
MRC and Biolex successfully complete collaboration to humanize BLX-301
Read More
Immunomedics enters worldwide license agreement with Nycomed for veltuzumab
Read More